MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 15.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 695,842 shares of the medical equipment provider's stock after selling 122,453 shares during the period. Intuitive Surgical accounts for 0.8% of MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s portfolio, making the stock its 17th largest position. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 0.19% of Intuitive Surgical worth $344,612,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Chilton Capital Management LLC grew its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares during the last quarter. Global Financial Private Client LLC grew its holdings in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares during the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. Finally, TD Capital Management LLC grew its holdings in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 45 shares during the last quarter. Institutional investors own 83.64% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on ISRG shares. Royal Bank Of Canada reiterated an "outperform" rating and set a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Deutsche Bank Aktiengesellschaft reiterated a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Truist Financial increased their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Citigroup restated a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, UBS Group raised their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $595.95.
Get Our Latest Report on ISRG
Insider Transactions at Intuitive Surgical
In other news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. This represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 in the last 90 days. 0.70% of the stock is currently owned by insiders.
Intuitive Surgical Stock Performance
Shares of Intuitive Surgical stock traded up $12.34 on Friday, hitting $466.86. 2,623,029 shares of the company's stock were exchanged, compared to its average volume of 2,035,305. The company has a 50-day simple moving average of $494.00 and a 200-day simple moving average of $512.08. The stock has a market capitalization of $167.36 billion, a PE ratio of 65.11, a PEG ratio of 4.89 and a beta of 1.61. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.78 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.